Probiotics show promise in stopping autoimmune diseases before they start

NCT ID NCT04014660

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving a daily mix of two types of friendly bacteria (Lactobacilli) to children at genetic risk could prevent or slow down autoimmune diseases like celiac disease, type 1 diabetes, and thyroid problems. The researchers enrolled 202 children who already had early signs of autoimmunity (specific antibodies in their blood). The goal was to see if these probiotics could calm the immune system and protect the gut, potentially stopping the disease from developing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELIAC DISEASE IN CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Research Center (CRC), Bldng 60:11

    Malmö, 20502, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.